agilon health, inc. (AGL) FY2026 Q2 P&L / Income Statement

agilon health, inc. (AGL) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue and costs use their disclosed categories.

Total revenues

1,494,743,000 US dollars

Cost of revenue (calculated)

1,387,604,000 US dollars

Gross profit (calculated)

107,139,000 US dollars

Operating expenses (calculated)

95,369,000 US dollars

Income (loss) from operations

11,770,000 US dollars

Other income (expense), net (calculated)

5,811,000 US dollars

Income (loss) before income taxes

17,581,000 US dollars

Income tax benefit (expense)

negative 375,000 US dollars

Net income (loss)

17,956,000 US dollars

Medical services revenue revenue

1,492,921,000 US dollars

Other operating revenue revenue

1,822,000 US dollars

Medical services revenue cost of revenue

1,296,235,000 US dollars

Other operating revenue cost of revenue

91,369,000 US dollars

General and administrative

88,505,000 US dollars

Depreciation and amortization

6,864,000 US dollars

Adjustments on sale of assets, net

0 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.